Anderson-Fabry Disease: Update in Diagnosis & Treatment (Enduring)
Anderson-Fabry Disease: Update in Diagnosis & Treatment (Enduring)
4.0 ACCME Credits, Video On-Demand/Enduring Program
June 07, 2024
9:00 AM - 1:15 PM (ET)

Program Overview: Anderson-Fabry Disease
VIDEO ON-DEMAND/ENDURING PROGRAM AVAILABLE ONLINE THRU JUNE 7, 2024
Hosted by Columbia University, Department of Medicine's Columbia Fabry Center, visit www.columbiafabry.org for more information.
The goal of this symposium is to expose health professionals and scientists with up-to-date information on Anderson-Fabry Disease.

Video Access
On registration, all registrants will be sent access to lecture video recordings available to watch thru June 7, 2024.


Learning Objectives
-Describe the pathophysiology of Fabry disease, including the molecular mechanisms underlying the accumulation of glycosphingolipids and the resulting cellular and tissue damage.
-Identify the clinical signs and symptoms of Fabry disease, including early and late-onset presentations, to facilitate early diagnosis and management of the disease.
-Evaluate the available diagnostic tools and techniques for Fabry disease, including genetic testing, enzyme activity assays, and imaging studies, to effectively diagnose the disease and guide appropriate treatment decisions.
-Develop a multidisciplinary management plan for patients with Fabry disease, including enzyme replacement therapy, pain management, and preventive measures to address the multisystem involvement of the disease and improve patient outcomes. This should also include the management of complications such as renal failure, cardiovascular disease, and stroke.

Target Audience
The course targets health professionals in the broad fields of primary care, pediatrics, geriatrics, neurology, psychology, psychiatry, and cardiology, as well as scientists. This course is open to medical doctors, researchers, nurses, physician assistants, fellows.


Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Columbia University. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Amedco Joint Accreditation #4008163.

Physicians (ACCME) Credit Designation Statement

Amedco LLC designates this live streaming activity for a maximum of 4.0
AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Physician Assistants

PAs may claim a maximum of 4.0 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.

 

Nurse Practitioners

The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education credit. Maximum of 4.0 hours.


Agenda
Click to View
Course Directors
Associate Professor of Pediatrics
Columbia University
Professor of Medicine, Clinical Director, Division of Nephrology
Columbia University

No records found.

Registration Fees

Registration Options
On-Demand Video Program
50.00 USD
On-Demand Video Program - CUIMC/NYP
0.00 USD
On-Demand Video Program - Patient
0.00 USD